Herold, Z.; Herold, M.; Lohinszky, J.; Dank, M.; Somogyi, A.
Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes. Cancers 2020, 12, 556.
https://doi.org/10.3390/cancers12030556
AMA Style
Herold Z, Herold M, Lohinszky J, Dank M, Somogyi A.
Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes. Cancers. 2020; 12(3):556.
https://doi.org/10.3390/cancers12030556
Chicago/Turabian Style
Herold, Zoltan, Magdolna Herold, Julia Lohinszky, Magdolna Dank, and Aniko Somogyi.
2020. "Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes" Cancers 12, no. 3: 556.
https://doi.org/10.3390/cancers12030556
APA Style
Herold, Z., Herold, M., Lohinszky, J., Dank, M., & Somogyi, A.
(2020). Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes. Cancers, 12(3), 556.
https://doi.org/10.3390/cancers12030556